Published in Urol Res on January 01, 1992
Fibroblast growth factor receptor 1 promotes proliferation and survival via activation of the mitogen-activated protein kinase pathway in bladder cancer. Cancer Res (2009) 1.16
A Decade of FGF Receptor Research in Bladder Cancer: Past, Present, and Future Challenges. Adv Urol (2012) 1.16
Molecular pathways in bladder cancer. Urol Res (2004) 0.95
A combination treatment with DNA methyltransferase inhibitors and suramin decreases invasiveness of breast cancer cells. Breast Cancer Res Treat (2014) 0.91
Altered splicing of FGFR1 is associated with high tumor grade and stage and leads to increased sensitivity to FGF1 in bladder cancer. Am J Pathol (2010) 0.84
A place for precision medicine in bladder cancer: targeting the FGFRs. Future Oncol (2016) 0.75
A rat model with an isolated bladder in situ. Surg Today (1997) 0.75
Collective migration of an epithelial monolayer in response to a model wound. Proc Natl Acad Sci U S A (2007) 4.35
Frequent FGFR3 mutations in papillary non-invasive bladder (pTa) tumors. Am J Pathol (2001) 2.55
EAU guidelines on prostate cancer. Eur Urol (2005) 1.88
Comparison of phytotherapy (Permixon) with finasteride in the treatment of benign prostate hyperplasia: a randomized international study of 1,098 patients. Prostate (1996) 1.85
Growth factors in skeletal muscle regeneration. Cytokine Growth Factor Rev (1996) 1.82
Evaluation of cellular tumour rejection mechanisms in the peritumoral bladder wall after bacillus Calmette-Guérin treatment. BJU Int (2001) 1.56
Perineal approach to radical prostatectomy in kidney transplant recipients with localized prostate cancer. Urology (1999) 1.50
Alternative splicing in fibroblast growth factor receptor 2 is associated with induced epithelial-mesenchymal transition in rat bladder carcinoma cells. Mol Biol Cell (1994) 1.46
The mitogenic signaling pathway of fibroblast growth factor is not mediated through polyphosphoinositide hydrolysis and protein kinase C activation in hamster fibroblasts. J Biol Chem (1986) 1.46
Laparoscopic radical prostatectomy: preliminary results. Urology (2000) 1.42
Modulation of cranial bone healing with a heparin-like dextran derivative. J Craniofac Surg (1996) 1.38
The use of acetone precipitation in the isolation of ribosomal proteins. Eur J Biochem (1976) 1.38
Acidic fibroblast growth factor is a modulator of epithelial plasticity in a rat bladder carcinoma cell line. Proc Natl Acad Sci U S A (1990) 1.37
Evaluation of quality of life after laparoscopic surgery: evidence-based guidelines of the European Association for Endoscopic Surgery. Surg Endosc (2004) 1.36
Fibroblast growth factor-2. Int J Biochem Cell Biol (2000) 1.34
gamma Heavy chain disease in man: cDNA sequence supports partial gene deletion model. Proc Natl Acad Sci U S A (1982) 1.27
Specific binding of angiogenin to calf pulmonary artery endothelial cells. Proc Natl Acad Sci U S A (1989) 1.27
Bovine retina contains three growth factor activities with different affinity to heparin: eye derived growth factor I, II, III. Biochimie (1985) 1.24
Creation of an hepatocyte growth factor/scatter factor autocrine loop in carcinoma cells induces invasive properties associated with increased tumorigenicity. Oncogene (1994) 1.24
Expression of MAGE genes in transitional-cell carcinomas of the urinary bladder. Int J Cancer (1995) 1.22
MCF7 mammary cancer cells respond to bFGF and internalize it following its release from extracellular matrix: a permissive role of cathepsin D. Exp Cell Res (1991) 1.19
Orchiectomy and nilutamide or placebo as treatment of metastatic prostatic cancer in a multinational double-blind randomized trial. J Urol (1993) 1.18
Retroperitoneal laparoscopy of a retrocaval ureter. BJU Int (1999) 1.17
Expression of transfected transforming growth factor alpha induces a motile fibroblast-like phenotype with extracellular matrix-degrading potential in a rat bladder carcinoma cell line. Cell Regul (1990) 1.16
Early removal of the catheter after laparoscopic radical prostatectomy. J Urol (2001) 1.14
The endogenous oxindoles 5-hydroxyoxindole and isatin are antiproliferative and proapoptotic. Biochem Biophys Res Commun (2000) 1.14
BCG intravesical instillations: recommendations for side-effects management. Eur Urol (2000) 1.14
Proposal for a "European Scoring System for Laparoscopic Operations in Urology". Eur Urol (2001) 1.13
Extraperitoneal laparoscopic pyeloplasty: a multicenter study of 55 procedures. J Urol (2001) 1.13
A scatter factor-like factor is produced by a metastatic variant of a rat bladder carcinoma cell line. J Cell Sci (1994) 1.11
Structure and function of the promoter-enhancer region of polyoma and SV40. Cold Spring Harb Symp Quant Biol (1983) 1.10
Experience with retroperitoneal laparoscopic adrenalectomy for pheochromocytoma. J Urol (2001) 1.09
Secreted or nonsecreted forms of acidic fibroblast growth factor produced by transfected epithelial cells influence cell morphology, motility, and invasive potential. Proc Natl Acad Sci U S A (1991) 1.08
Modulations of the epithelial phenotype during embryogenesis and cancer progression. Cancer Treat Res (1994) 1.07
Purification, characterization, and biological properties of the eye-derived growth factor from retina: analogies with brain-derived growth factor. J Neurosci Res (1982) 1.06
A preoperative clinical prognostic model for non-metastatic renal cell carcinoma. BJU Int (2003) 1.05
Specific fixation of bovine brain and retinal acidic and basic fibroblast growth factors to mouse embryonic eye basement membranes. Exp Cell Res (1987) 1.05
Retroperitoneal laparoscopic versus open radical nephrectomy. J Urol (1999) 1.05
Outcome of radical cystectomy for bladder cancer according to the disease type at presentation. BJU Int (2002) 1.05
Laparoscopic promontory sacral colpopexy: is the posterior, recto-vaginal, mesh mandatory? Eur Urol (2004) 1.05
Mitogenic properties of a new endothelial cell growth factor related to pleiotrophin. Biochem Biophys Res Commun (1991) 1.04
The pathophysiology of pelvic floor disorders: evidence from a histomorphologic study of the perineum and a mouse model of rectal prolapse. J Anat (2001) 1.02
Mitogenic and in vitro angiogenic activity of human recombinant heparin affin regulatory peptide. Growth Factors (1994) 1.01
Donor pretreatment as an adjunct to cadaver renal allotransplantation. Transplant Proc (1975) 1.01
Development of laparoscopic surgery and training facilities in Europe: results of a survey of the European Society of Uro-Technology (ESUT). Eur Urol (2004) 1.00
EAU guidelines on prostate cancer. Eur Urol (2001) 0.99
Serum markers as a predictor of response duration and patient survival after hormonal therapy for metastatic carcinoma of the prostate. J Urol (1997) 0.99
Multi-institutional study of complications in 1085 laparoscopic urologic procedures. Urology (2001) 0.99
Interstitial radiation therapy for carcinoma of the penis using iridium 192 wires: the Henri Mondor experience (1970-1979). Int J Radiat Oncol Biol Phys (1984) 0.97
Acidic FGF and other growth factors in preretinal membranes from patients with diabetic retinopathy and proliferative vitreoretinopathy. Ophthalmic Res (1991) 0.97
Both early and late control sequences of SV40 and polyoma promote transcription of Escherichia coli gpt gene in transfected cells. EMBO J (1982) 0.97
Immune response following intravesical bacillus Calmette-Guerin instillations in superficial bladder cancer: a review. Urol Res (1998) 0.96
Modulation of cytokeratin subtype, EGF receptor, and androgen receptor expression during progression of prostate cancer. Hum Pathol (1998) 0.96
Evidence and characterization of the receptor to eye-derived growth factor I, the retinal form of basic fibroblast growth factor, on bovine epithelial lens cells. Proc Natl Acad Sci U S A (1986) 0.95
Laparoscopic radical prostatectomy. The Créteil experience. Eur Urol (2001) 0.94
Magnetic resonance imaging of penile rupture: aid to diagnosis. J Urol (1995) 0.93
Partial nephrectomy with retroperitoneal laparoscopy. J Urol (1999) 0.93
Milk fat globule--epidermal growth factor--factor VIII (MFGE8)/lactadherin promotes bladder tumor development. Oncogene (2010) 0.92
Low E-cadherin expression in bladder cancer at the transcriptional and protein level provides prognostic information. Br J Cancer (2000) 0.92
[Pilot study of a new matrix therapy agent (RGTA OTR4120) in treatment-resistant corneal ulcers and corneal dystrophy]. J Fr Ophtalmol (2008) 0.92
Early and late mitogenic events induced by FGF on bovine epithelial lens cells are not triggered by hydrolysis of polyphosphoinositides. Biochem Biophys Res Commun (1987) 0.91
Immunological study of acidic fibroblast growth factor (aFGF) distribution in the eye. J Cell Biochem (1989) 0.91
Involvement of heparin affin regulatory peptide in human prostate cancer. Prostate (1999) 0.91
Needle tract seeding following puncture of renal oncocytoma. Prog Clin Biol Res (1982) 0.91
Value of ultrasound-guided systematic sextant biopsies in prostate tumor mapping. Eur Urol (1999) 0.91
Interactions of FGFs with target cells. Prog Growth Factor Res (1992) 0.90
Laparoscopic radical prostatectomy: preliminary results. Eur Urol (2000) 0.90
Prospective patient-reported continence after laparoscopic radical prostatectomy. Urology (2001) 0.90
Is there a ubiquitous growth factor in the eye? Proliferation induced in different cell types by eye-derived growth factors. Differentiation (1981) 0.90
Eye-derived growth factor isolated from bovine retina and used for epidermal wound healing in vivo. J Invest Dermatol (1986) 0.90
The prognostic value of p53 nuclear overexpression and MIB-1 as a proliferative marker in transitional cell carcinoma of the bladder. Cancer (1997) 0.89
Laparoscopic adrenalectomy: the retroperitoneal approach. J Urol (1998) 0.89
Human plasmin enzymatic activity is inhibited by chemically modified dextrans. J Biol Chem (2000) 0.89
Prognostic factors in superficial bladder cancer. World J Urol (1993) 0.89
Symptomatic caliceal diverticula treated with extraperitoneal laparoscopic marsupialization fulguration and gelatin resorcinol formaldehyde glue obliteration. J Urol (1998) 0.89
Derivatized dextrans mimic heparin as stabilizers, potentiators, and protectors of acidic or basic FGF. J Cell Physiol (1992) 0.89
Relationship between penile thermal sensory threshold measurement and electrophysiologic tests to assess neurogenic impotence. Urology (2001) 0.89
Matrix therapy in regenerative medicine, a new approach to chronic wound healing. J Biomed Mater Res A (2009) 0.89
Long-term functional and oncological results after retroperitoneal laparoscopic prostatectomy according to a prospective evaluation of 550 patients. World J Urol (2006) 0.88
Effect of heparin on bovine epithelial lens cell proliferation induced by heparin affin regulatory peptide. J Cell Physiol (1995) 0.88
Expression and functions of EGF, FGF and TGFbeta-growth-factor family members and their receptors in invasive human transitional-cell-carcinoma cells. Int J Cancer (1997) 0.87